The global drug discovery assays market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for personalized medicine and rising number of clinical trials. The major players in the global drug discovery assays market are Thermo Fisher Scientific Inc, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, PerkinElmer, Inc, Danaher Corporation, and Waters Corporation.
2) Increasing research and development activities in the pharmaceutical industry are also expected to fuel growth in this market over the next few years.
Some Of The Growth Factors Of This Market:
- Increasing research and development activities in the pharmaceutical industry are also expected to fuel growth in this market over the next few years.
Industry Growth Insights published a new data on “Drug Discovery Assays Market”. The research report is titled “Drug Discovery Assays Market research by Types (Consumables, Instruments, Services, Software), By Applications (Pharmaceutical and Biotechnology Companies, Academic and Government Institutions, Contract Research Organizations, Others, ), By Players/Companies Thermo Fisher Scientific, Danaher, Becton Dickinson, GE Healthcare, Merck, Lonza, PerkinElmer, Inc., Charles River Laboratories, Inc., Cell Signaling Technologies, Cisbio, Cell Biolabs, Inc., Promega, ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Discovery Assays Market Research Report
By Type
Consumables, Instruments, Services, Software
By Application
Pharmaceutical and Biotechnology Companies, Academic and Government Institutions, Contract Research Organizations, Others,
By Companies
Thermo Fisher Scientific, Danaher, Becton Dickinson, GE Healthcare, Merck, Lonza, PerkinElmer, Inc., Charles River Laboratories, Inc., Cell Signaling Technologies, Cisbio, Cell Biolabs, Inc., Promega,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Drug Discovery Assays Market Report Segments:
The global Drug Discovery Assays market is segmented on the basis of:
Types
Consumables, Instruments, Services, Software
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and Biotechnology Companies, Academic and Government Institutions, Contract Research Organizations, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Danaher
- Becton Dickinson
- GE Healthcare
- Merck
- Lonza
- PerkinElmer, Inc.
- Charles River Laboratories, Inc.
- Cell Signaling Technologies
- Cisbio
- Cell Biolabs, Inc.
- Promega
Highlights of The Drug Discovery Assays Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Consumables
- Instruments
- Services
- Software
- By Application:
- Pharmaceutical and Biotechnology Companies
- Academic and Government Institutions
- Contract Research Organizations
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Discovery Assays Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug discovery assays are a set of tests used to identify potential drugs or drug candidates. These tests can be used to screen large numbers of compounds for their ability to inhibit or activate specific proteins, receptors, or other molecules in cells.
Some of the key players operating in the drug discovery assays market are Thermo Fisher Scientific, Danaher, Becton Dickinson, GE Healthcare, Merck, Lonza, PerkinElmer, Inc., Charles River Laboratories, Inc., Cell Signaling Technologies, Cisbio, Cell Biolabs, Inc., Promega.
The drug discovery assays market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Discovery Assays Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Discovery Assays Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Discovery Assays Market - Supply Chain
4.5. Global Drug Discovery Assays Market Forecast
4.5.1. Drug Discovery Assays Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Discovery Assays Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug Discovery Assays Market Absolute $ Opportunity
5. Global Drug Discovery Assays Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug Discovery Assays Market Size and Volume Forecast by Type
5.3.1. Consumables
5.3.2. Instruments
5.3.3. Services
5.3.4. Software
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug Discovery Assays Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug Discovery Assays Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical and Biotechnology Companies
6.3.2. Academic and Government Institutions
6.3.3. Contract Research Organizations
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug Discovery Assays Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug Discovery Assays Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug Discovery Assays Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug Discovery Assays Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug Discovery Assays Demand Share Forecast, 2019-2026
9. North America Drug Discovery Assays Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug Discovery Assays Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug Discovery Assays Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical and Biotechnology Companies
9.4.2. Academic and Government Institutions
9.4.3. Contract Research Organizations
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug Discovery Assays Market Size and Volume Forecast by Type
9.7.1. Consumables
9.7.2. Instruments
9.7.3. Services
9.7.4. Software
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug Discovery Assays Demand Share Forecast, 2019-2026
10. Latin America Drug Discovery Assays Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug Discovery Assays Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug Discovery Assays Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Academic and Government Institutions
10.4.3. Contract Research Organizations
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug Discovery Assays Market Size and Volume Forecast by Type
10.7.1. Consumables
10.7.2. Instruments
10.7.3. Services
10.7.4. Software
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug Discovery Assays Demand Share Forecast, 2019-2026
11. Europe Drug Discovery Assays Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug Discovery Assays Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug Discovery Assays Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Academic and Government Institutions
11.4.3. Contract Research Organizations
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug Discovery Assays Market Size and Volume Forecast by Type
11.7.1. Consumables
11.7.2. Instruments
11.7.3. Services 11.7.4. Software
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug Discovery Assays Demand Share, 2019-2026
12. Asia Pacific Drug Discovery Assays Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug Discovery Assays Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug Discovery Assays Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Academic and Government Institutions
12.4.3. Contract Research Organizations
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug Discovery Assays Market Size and Volume Forecast by Type
12.7.1. Consumables
12.7.2. Instruments
12.7.3. Services
12.7.4. Software
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug Discovery Assays Demand Share, 2019-2026
13. Middle East & Africa Drug Discovery Assays Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug Discovery Assays Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug Discovery Assays Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Academic and Government Institutions
13.4.3. Contract Research Organizations
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug Discovery Assays Market Size and Volume Forecast by Type
13.7.1. Consumables
13.7.2. Instruments
13.7.3. Services
13.7.4. Software
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug Discovery Assays Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drug Discovery Assays Market: Market Share Analysis
14.2. Drug Discovery Assays Distributors and Customers
14.3. Drug Discovery Assays Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Danaher
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Becton Dickinson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GE Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Merck
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Lonza
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. PerkinElmer, Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Charles River Laboratories, Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cell Signaling Technologies
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cisbio
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cell Biolabs, Inc.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Promega
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
